Navigation Links
Atraumatic Spring Jaw Babcock Forceps

ProductsAtraumatic Spring Jaw Babcock Forceps
Company Mediflex Surgical Products
Item Atraumatic Spring Jaw Babcock Forceps
Features 
  • Special order
  • One Piece or Modular
  • 10mm diameter
  • 33cm length
  • 45cm lengths available upon request
  • Modular instruments may be customized.
    • Description Many special order products are offered as 1-piece or modular, in regular or extra long lengths. The modular instruments may be customized with handles of choice and other options such as ratchets, insulation and flush ports. Many standard patterns are available from Mediflex stock. Customer specifications may affect delivery times.

    Please Note: Individual instrument components, such as handles, inserts, and shafts, are available by request.
    Info Mediflex Surgical Products
    Customer Service: (800) 879-7575
    Web site: http://www.mediflex.com/

    Related medicine products :

    1. Atraumatic Phaco Fixation Ring, 12mm Diameter
    2. Atraumatic Phaco Fixation Ring
    3. Short Atraumatic Grasper
    4. Atraumatic Grasper
    5. Endo Cinch Extreme Atraumatic
    6. Atraumatic Endo- Clinch Grasper
    7. Atraumatic Grasping Forceps
    8. Graspers Atraumatic
    9. Perc NCircle® Rapid Atraumatic PCNL Stone Extractor
    10. Atraumatic Grasping Forceps (Fallopian), dual-incision
    11. Yasargil Spring Hool with Bulldog Clamp
    A sophisticated research tool that allows to see the fundus picture of the area which is being stimulated. Besides it also includes the refractive pupil camera enabling the examiner to switch between
    5 mm
    Cannula and irrigation extension. Overall Length 150 mm (6.25"). Light Curve.
    Produce clean 0.75 mm round hole without tissue tags. Serrated squeeze action handle.
    Medicine Products:
    (Date:7/18/2008)...est weight loss yields significant health benefits...oalition -- a group of,experts on overweight and o...dia to reevaluate the way they report on weight lo...ed news coverage and editorial content that,leads ... dieters if they,lose an enormous amount of weight...
    (Date:7/18/2008)...n Is Not What America Signed Up For, WASHINGTON, ... McCain,s,top economic advisor, Phil Gramm, echoed...s were "psychological" by saying Americans are in ... "nation of whiners." While McCain,distanced himse...ard as,McCain,s top economic adviser. Now, John Mc...
    (Date:7/18/2008)... Behavior spanning the wide spectrum of the animal...rnational Behavioral Ecology Congress, hosted by t...n Aug. 10 -14, 2008, at Cornell University in Itha...e congress will feature plenary sessions on: , ...olutionary biology, Yale University, on "When Theo...
    (Date:7/18/2008)...ren preventive antibiotics within one hour before ...sk for serious infections after the surgery, sugge...ugust issue of Pediatric Infectious Disease Journ...en who received antibiotics outside of the golden ...ely to develop serious infections at the surgery s...
    Breaking Medicine News(10 mins):Health News:Medical Experts Call on Media to Rethink Coverage of Weight Loss 2Health News:Medical Experts Call on Media to Rethink Coverage of Weight Loss 3Health News:DNC: McCain Watch: The Economy 2Health News:DNC: McCain Watch: The Economy 3Health News:Averting postsurgical infections in kids: Give antibiotics within hour before first incision 2
    ...y probably be small if the trip isn't to Asia. Pub...ntly known about the virus. However people can be ...strong filters against viruses. There have even be...s as possible. Newer flights are equipped with sop...
    ...ritish Medical Association (BMA) is advising peopl...isks. While the government does not recommend the ...their use. A report from WHO calls for an urgent n... of increased ultra-violet exposure. A tan, even w...
    ...e lifestyle with limiting TV time could prevent ob...n the US TV watching results in a lower metabolic ...ing board games, reading, writing or driving a car... in children. The health campaigns are focussed on...
    ...an detrimental effect on infant's brain, reducing ...med, it a reason behind increasing language learni...societies, the hearing center of a baby's sensitiv...iment conducted on young rats, the hearing center,...
    Other Medicine News:
    (Date:7/16/2008)... INTERNATIONAL AIDS SOCIETY AND KAISER FAMILY FOU...RAGE OF CONFERENCE FOR FREE, MENLO PARK, Calif., ...,International AIDS Society (IAS) and the Kaiser F...ess to the XVII International AIDS Conference,(AID...ugust 2008. Kaiser --,an independent operating fou...
    (Date:7/16/2008)...Expanded Collaboration Supports Pivotal Phase 2b C...dress an Underlying Cause of Cystic Fibrosis -, S...- PTC,Therapeutics, Inc. (PTC) and Cy..., the nonprofit affiliate of the Cystic Fibrosis F...sting collaboration to support development,of PTC1...
    (Date:7/15/2008)... - Company Reports Favorable Phase 1 RX-33...re/ -- Rib-X Pharmaceuticals, Inc.,("Rib-X" or the...n the,discovery and development of novel antibioti...tions, today announced the initiation of a Phase,2...tic compound RX-3341 in,the treatment of complicat...
    (Date:7/15/2008)... BOSTON, July 15 /-Scimitar Equity, ...Board: ADXS), entitled, "The New Generation of,Can...e at website: http://www.scimitarequity.com ., B...is developing,proprietary Listeria monocytogenes (...d by Dr. Yvonne Paterson, Professor of Microbiolog...
    Breaking Medicine Technology:Online Coverage of International AIDS Conference Includes Daily Webcasts, Podcasts and Interviews 2Online Coverage of International AIDS Conference Includes Daily Webcasts, Podcasts and Interviews 3Online Coverage of International AIDS Conference Includes Daily Webcasts, Podcasts and Interviews 4PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 2PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 3PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124 4Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 2Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections 3Advaxis, Inc Initiation Coverage Review Issued By Scimitar Equity, LLC 2High Fat Diet Can Disrupt Bodys Clock 5652 1High Fat Diet Can Disrupt Bodys Clock 5652 2AIM Quoted Verona Pharma Progresses Anti Asthma Drug Studies 1705 1AIM Quoted Verona Pharma Progresses Anti Asthma Drug Studies 1705 2Frontiers in Cancer Prevention Research 1128 1New Study Reveals MRSA Bacteria Common Among Pigs and Farm Workers 5647 1New Study Reveals MRSA Bacteria Common Among Pigs and Farm Workers 5647 2New Study Reveals MRSA Bacteria Common Among Pigs and Farm Workers 5647 3
    ...ined Improvements in Blood Glucose,Control and Pro...Newswire-FirstCall/ -- Amylin,Pharmaceuticals, Inc...s from a study that showed BYETTA(R) (exenatide) i...els and progressive weight,loss through three and ... associated with improvements in cardiovascular ri...
    ...INESS WIRE)--June 25, 2007--Gilead,Sciences, Inc. ...ase III clinical trial evaluating the company,s on...oxil fumarate or tenofovir,DF) 300 mg as a potenti...nfection, met its primary efficacy endpoint. The d...y,s once-daily antiviral,drug Hepsera(R) (adefovir...
    Other Medicine Technology:Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 2Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 3Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 4Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 5Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 6Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6